Global Avian Influenza Vaccines Market Insights and Forecast to 2027

Publisher Name :
Date: 01-Jun-2021
No. of pages: 118
Inquire Before Buying

Avian Influenza Vaccines market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Avian Influenza Vaccines market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2016-2027.

Segment by Type

- Type H5

- Type H9

- Other

Segment by Application

- Chicken

- Duck & Goose

- Other

By Company

- Merial

- CEVA

- Zoetis

- Elanco (Lohmann )

- Merck Animal Health

- Avimex Animal Health

By Region

- North America

- - U.S.

- - Canada

- Europe

- - Germany

- - France

- - U.K.

- - Italy

- - Russia

- Asia-Pacific

- - China

- - Japan

- - South Korea

- - India

- - Australia

- - Taiwan

- - Indonesia

- - Thailand

- - Malaysia

- - Philippines

- - Vietnam

- Latin America

- - Mexico

- - Brazil

- - Argentina

- Middle East & Africa

- - Turkey

- - Saudi Arabia

Global Avian Influenza Vaccines Market Insights and Forecast to 2027

Table of Contents
1 Study Coverage
1.1 Avian Influenza Vaccines Product Introduction
1.2 Market by Type
1.2.1 Global Avian Influenza Vaccines Market Size Growth Rate by Type
1.4.2 Type H5
1.4.3 Type H9
1.2.4 Other
1.3 Market by Application
1.3.1 Global Avian Influenza Vaccines Market Size Growth Rate by Application
1.3.2 Chicken
1.3.3 Duck & Goose
1.3.4 Other
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global Avian Influenza Vaccines Sales Estimates and Forecasts 2016-2027
2.2 Global Avian Influenza Vaccines Revenue Estimates and Forecasts 2016-2027
2.3 Global Avian Influenza Vaccines Revenue by Region: 2016 VS 2021 VS 2027
2.4 Global Top Avian Influenza Vaccines Regions by Sales
2.4.1 Global Top Avian Influenza Vaccines Regions by Sales (2016-2021)
2.4.2 Global Top Avian Influenza Vaccines Regions by Sales (2022-2027)
2.5 Global Top Avian Influenza Vaccines Regions by Revenue
2.5.1 Global Top Avian Influenza Vaccines Regions by Revenue (2016-2021)
2.5.2 Global Top Avian Influenza Vaccines Regions by Revenue (2022-2027)
2.6 North America
2.7 Europe
2.8 Asia-Pacific
2.9 Latin America
2.10 Middle East & Africa
3 Competition by Manufacturers
3.1 Global Avian Influenza Vaccines Sales by Manufacturers
3.1.1 Global Top Avian Influenza Vaccines Manufacturers by Sales (2016-2021)
3.1.2 Global Top Avian Influenza Vaccines Manufacturers Market Share by Sales (2016-2021)
3.1.3 Global Top 10 and Top 5 Companies by Avian Influenza Vaccines Sales in 2020
3.2 Global Avian Influenza Vaccines Revenue by Manufacturers
3.2.1 Global Top Avian Influenza Vaccines Manufacturers by Revenue (2016-2021)
3.2.2 Global Top Avian Influenza Vaccines Manufacturers Market Share by Revenue (2016-2021)
3.2.3 Global Top 10 and Top 5 Companies by Avian Influenza Vaccines Revenue in 2020
3.3 Global Avian Influenza Vaccines Sales Price by Manufacturers
3.4 Analysis of Competitive Landscape
3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Avian Influenza Vaccines Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4.3 Global Avian Influenza Vaccines Manufacturers Geographical Distribution
3.5 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Global Avian Influenza Vaccines Sales by Type
4.1.1 Global Avian Influenza Vaccines Historical Sales by Type (2016-2021)
4.1.2 Global Avian Influenza Vaccines Forecasted Sales by Type (2022-2027)
4.1.3 Global Avian Influenza Vaccines Sales Market Share by Type (2016-2027)
4.2 Global Avian Influenza Vaccines Revenue by Type
4.2.1 Global Avian Influenza Vaccines Historical Revenue by Type (2016-2021)
4.2.2 Global Avian Influenza Vaccines Forecasted Revenue by Type (2022-2027)
4.2.3 Global Avian Influenza Vaccines Revenue Market Share by Type (2016-2027)
4.3 Global Avian Influenza Vaccines Price by Type
4.3.1 Global Avian Influenza Vaccines Price by Type (2016-2021)
4.3.2 Global Avian Influenza Vaccines Price Forecast by Type (2022-2027)
5 Market Size by Application
5.1 Global Avian Influenza Vaccines Sales by Application
5.1.1 Global Avian Influenza Vaccines Historical Sales by Application (2016-2021)
5.1.2 Global Avian Influenza Vaccines Forecasted Sales by Application (2022-2027)
5.1.3 Global Avian Influenza Vaccines Sales Market Share by Application (2016-2027)
5.2 Global Avian Influenza Vaccines Revenue by Application
5.2.1 Global Avian Influenza Vaccines Historical Revenue by Application (2016-2021)
5.2.2 Global Avian Influenza Vaccines Forecasted Revenue by Application (2022-2027)
5.2.3 Global Avian Influenza Vaccines Revenue Market Share by Application (2016-2027)
5.3 Global Avian Influenza Vaccines Price by Application
5.3.1 Global Avian Influenza Vaccines Price by Application (2016-2021)
5.3.2 Global Avian Influenza Vaccines Price Forecast by Application (2022-2027)
6 North America
6.1 North America Avian Influenza Vaccines Market Size by Type
6.1.1 North America Avian Influenza Vaccines Sales by Type (2016-2027)
6.1.2 North America Avian Influenza Vaccines Revenue by Type (2016-2027)
6.2 North America Avian Influenza Vaccines Market Size by Application
6.2.1 North America Avian Influenza Vaccines Sales by Application (2016-2027)
6.2.2 North America Avian Influenza Vaccines Revenue by Application (2016-2027)
6.3 North America Avian Influenza Vaccines Market Size by Country
6.3.1 North America Avian Influenza Vaccines Sales by Country (2016-2027)
6.3.2 North America Avian Influenza Vaccines Revenue by Country (2016-2027)
6.3.3 U.S.
6.3.4 Canada
7 Europe
7.1 Europe Avian Influenza Vaccines Market Size by Type
7.1.1 Europe Avian Influenza Vaccines Sales by Type (2017-2027)
7.1.2 Europe Avian Influenza Vaccines Revenue by Type (2017-2027)
7.2 Europe Avian Influenza Vaccines Market Size by Application
7.2.1 Europe Avian Influenza Vaccines Sales by Application (2017-2027)
7.2.2 Europe Avian Influenza Vaccines Revenue by Application (2017-2027)
7.3 Europe Avian Influenza Vaccines Market Size by Country
7.3.1 Europe Avian Influenza Vaccines Sales by Country (2017-2027)
7.3.2 Europe Avian Influenza Vaccines Revenue by Country (2017-2027)
7.3.3 Germany
7.3.4 France
7.3.5 U.K.
7.3.6 Italy
7.3.7 Russia
8 Asia Pacific
8.1 Asia Pacific Avian Influenza Vaccines Market Size by Type
8.1.1 Asia Pacific Avian Influenza Vaccines Sales by Type (2018-2027)
8.1.2 Asia Pacific Avian Influenza Vaccines Revenue by Type (2018-2027)
8.2 Asia Pacific Avian Influenza Vaccines Market Size by Application
8.2.1 Asia Pacific Avian Influenza Vaccines Sales by Application (2018-2027)
8.2.2 Asia Pacific Avian Influenza Vaccines Revenue by Application (2018-2027)
8.3 Asia Pacific Avian Influenza Vaccines Market Size by Region
8.3.1 Asia Pacific Avian Influenza Vaccines Sales by Region (2018-2027)
8.3.2 Asia Pacific Avian Influenza Vaccines Revenue by Region (2018-2027)
8.3.3 China
8.3.4 Japan
8.3.5 South Korea
8.3.6 India
8.3.7 Australia
8.3.8 Taiwan
8.3.9 Indonesia
8.3.10 Thailand
8.3.11 Malaysia
8.3.12 Philippines
9 Latin America
9.1 Latin America Avian Influenza Vaccines Market Size by Type
9.1.1 Latin America Avian Influenza Vaccines Sales by Type (2019-2027)
9.1.2 Latin America Avian Influenza Vaccines Revenue by Type (2019-2027)
9.2 Latin America Avian Influenza Vaccines Market Size by Application
9.2.1 Latin America Avian Influenza Vaccines Sales by Application (2019-2027)
9.2.2 Latin America Avian Influenza Vaccines Revenue by Application (2019-2027)
9.3 Latin America Avian Influenza Vaccines Market Size by Country
9.3.1 Latin America Avian Influenza Vaccines Sales by Country (2019-2027)
9.3.2 Latin America Avian Influenza Vaccines Revenue by Country (2019-2027)
9.3.3 Mexico
9.3.4 Brazil
9.3.5 Argentina
6 Middle East and Africa
6.1 Middle East and Africa Avian Influenza Vaccines Market Size by Type
6.1.1 Middle East and Africa Avian Influenza Vaccines Sales by Type (2016-2027)
6.1.2 Middle East and Africa Avian Influenza Vaccines Revenue by Type (2016-2027)
6.2 Middle East and Africa Avian Influenza Vaccines Market Size by Application
6.2.1 Middle East and Africa Avian Influenza Vaccines Sales by Application (2016-2027)
6.2.2 Middle East and Africa Avian Influenza Vaccines Revenue by Application (2016-2027)
6.3 Middle East and Africa Avian Influenza Vaccines Market Size by Country
6.3.1 Middle East and Africa Avian Influenza Vaccines Sales by Country (2016-2027)
6.3.2 Middle East and Africa Avian Influenza Vaccines Revenue by Country (2016-2027)
6.3.3 Turkey
6.3.4 Saudi Arabia
6.3.5 U.A.E
11 Company Profiles
11.1 Merial
11.1.1 Merial Corporation Information
11.1.2 Merial Overview
11.1.3 Merial Avian Influenza Vaccines Sales, Price, Revenue and Gross Margin (2016-2021)
11.1.4 Merial Avian Influenza Vaccines Product Description
11.1.5 Merial Related Developments
11.2 CEVA
11.2.1 CEVA Corporation Information
11.2.2 CEVA Overview
11.2.3 CEVA Avian Influenza Vaccines Sales, Price, Revenue and Gross Margin (2016-2021)
11.2.4 CEVA Avian Influenza Vaccines Product Description
11.2.5 CEVA Related Developments
11.3 Zoetis
11.3.1 Zoetis Corporation Information
11.3.2 Zoetis Overview
11.3.3 Zoetis Avian Influenza Vaccines Sales, Price, Revenue and Gross Margin (2016-2021)
11.3.4 Zoetis Avian Influenza Vaccines Product Description
11.3.5 Zoetis Related Developments
11.4 Elanco (Lohmann )
11.4.1 Elanco (Lohmann ) Corporation Information
11.4.2 Elanco (Lohmann ) Overview
11.4.3 Elanco (Lohmann ) Avian Influenza Vaccines Sales, Price, Revenue and Gross Margin (2016-2021)
11.4.4 Elanco (Lohmann ) Avian Influenza Vaccines Product Description
11.4.5 Elanco (Lohmann ) Related Developments
11.5 Merck Animal Health
11.5.1 Merck Animal Health Corporation Information
11.5.2 Merck Animal Health Overview
11.5.3 Merck Animal Health Avian Influenza Vaccines Sales, Price, Revenue and Gross Margin (2016-2021)
11.5.4 Merck Animal Health Avian Influenza Vaccines Product Description
11.5.5 Merck Animal Health Related Developments
11.6 Avimex Animal Health
11.6.1 Avimex Animal Health Corporation Information
11.6.2 Avimex Animal Health Overview
11.6.3 Avimex Animal Health Avian Influenza Vaccines Sales, Price, Revenue and Gross Margin (2016-2021)
11.6.4 Avimex Animal Health Avian Influenza Vaccines Product Description
11.6.5 Avimex Animal Health Related Developments
11.1 Merial
11.1.1 Merial Corporation Information
11.1.2 Merial Overview
11.1.3 Merial Avian Influenza Vaccines Sales, Price, Revenue and Gross Margin (2016-2021)
11.1.4 Merial Avian Influenza Vaccines Product Description
11.1.5 Merial Related Developments
12 Value Chain and Sales Channels Analysis
12.1 Avian Influenza Vaccines Value Chain Analysis
12.2 Avian Influenza Vaccines Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Avian Influenza Vaccines Production Mode & Process
12.4 Avian Influenza Vaccines Sales and Marketing
12.4.1 Avian Influenza Vaccines Sales Channels
12.4.2 Avian Influenza Vaccines Distributors
12.5 Avian Influenza Vaccines Customers
13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis
13.1 Avian Influenza Vaccines Industry Trends
13.2 Avian Influenza Vaccines Market Drivers
13.3 Avian Influenza Vaccines Market Challenges
13.4 Avian Influenza Vaccines Market Restraints
14 Key Findings in The Global Avian Influenza Vaccines Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer
List of Tables
Table 1. Global Avian Influenza Vaccines Market Size Growth Rate by Type, 2016 VS 2021 VS 2027 (US$ Million)
Table 2. Major Manufacturers of Type H5
Table 3. Major Manufacturers of Type H9
Table 4. Major Manufacturers of Other
Table 5. Global Avian Influenza Vaccines Market Size Growth Rate by Application, 2016 VS 2021 VS 2027 (US$ Million)
Table 6. Global Avian Influenza Vaccines Revenue by Region: 2016 VS 2021 VS 2027 (US$ Million)
Table 7. Global Avian Influenza Vaccines Sales by Region (2016-2021) & (M Doses)
Table 8. Global Avian Influenza Vaccines Sales Market Share by Region (2016-2021)
Table 9. Global Avian Influenza Vaccines Sales by Region (2016-2021) & (M Doses)
Table 10. Global Avian Influenza Vaccines Sales Market Share by Region (2022-2027)
Table 11. Global Avian Influenza Vaccines Revenue by Region (2016-2021) & (US$ Million)
Table 12. Global Avian Influenza Vaccines Revenue Market Share by Region (2016-2021)
Table 13. Global Avian Influenza Vaccines Revenue by Region (2022-2027) & (US$ Million)
Table 14. Global Avian Influenza Vaccines Revenue Market Share by Region (2022-2027)
Table 15. Global Avian Influenza Vaccines Sales by Manufacturers (2016-2021) & (M Doses)
Table 16. Global Avian Influenza Vaccines Sales Share by Manufacturers (2016-2021)
Table 17. Global Avian Influenza Vaccines Revenue by Manufacturers (2016-2021) & (US$ Million)
Table 18. Global Avian Influenza Vaccines Revenue Share by Manufacturers (2016-2021)
Table 19. Avian Influenza Vaccines Price by Manufacturers 2016-2021 (USD/K Doses)
Table 20. Global Avian Influenza Vaccines Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 21. Global Avian Influenza Vaccines by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Avian Influenza Vaccines as of 2020)
Table 22. Avian Influenza Vaccines Manufacturing Base Distribution and Headquarters
Table 23. Manufacturers Avian Influenza Vaccines Product Offered
Table 24. Date of Manufacturers Enter into Avian Influenza Vaccines Market
Table 25. Mergers & Acquisitions, Expansion Plans
Table 26. Global Avian Influenza Vaccines Sales by Type (2016-2021) & (M Doses)
Table 27. Global Avian Influenza Vaccines Sales by Type (2022-2027) & (M Doses)
Table 28. Global Avian Influenza Vaccines Sales Share by Type (2016-2021)
Table 29. Global Avian Influenza Vaccines Sales Share by Type (2022-2027)
Table 30. Global Avian Influenza Vaccines Revenue by Type (2016-2021) & (US$ Million)
Table 31. Global Avian Influenza Vaccines Revenue by Type (2022-2027) & (US$ Million)
Table 32. Global Avian Influenza Vaccines Revenue Share by Type (2016-2021)
Table 33. Global Avian Influenza Vaccines Revenue Share by Type (2022-2027)
Table 34. Avian Influenza Vaccines Price by Type (2016-2021) & (USD/K Doses)
Table 35. Global Avian Influenza Vaccines Price Forecast by Type (2022-2027) & (USD/K Doses)
Table 36. Global Avian Influenza Vaccines Sales by Application (2016-2021) & (M Doses)
Table 37. Global Avian Influenza Vaccines Sales by Application (2022-2027) & (M Doses)
Table 38. Global Avian Influenza Vaccines Sales Share by Application (2016-2021)
Table 39. Global Avian Influenza Vaccines Sales Share by Application (2022-2027)
Table 40. Global Avian Influenza Vaccines Revenue by Application (2016-2021) & (US$ Million)
Table 41. Global Avian Influenza Vaccines Revenue by Application (2022-2027) & (US$ Million)
Table 42. Global Avian Influenza Vaccines Revenue Share by Application (2016-2021)
Table 43. Global Avian Influenza Vaccines Revenue Share by Application (2022-2027)
Table 44. Avian Influenza Vaccines Price by Application (2016-2021) & (USD/K Doses)
Table 45. Global Avian Influenza Vaccines Price Forecast by Application (2022-2027) & (USD/K Doses)
Table 46. North America Avian Influenza Vaccines Sales by Type (2016-2021) & (M Doses)
Table 47. North America Avian Influenza Vaccines Sales by Type (2022-2027) & (M Doses)
Table 48. North America Avian Influenza Vaccines Revenue by Type (2016-2021) & (US$ Million)
Table 49. North America Avian Influenza Vaccines Revenue by Type (2022-2027) & (US$ Million)
Table 50. North America Avian Influenza Vaccines Sales by Application (2016-2021) & (M Doses)
Table 51. North America Avian Influenza Vaccines Sales by Application (2022-2027) & (M Doses)
Table 52. North America Avian Influenza Vaccines Revenue by Application (2016-2021) & (US$ Million)
Table 53. North America Avian Influenza Vaccines Revenue by Application (2022-2027) & (US$ Million)
Table 54. North America Avian Influenza Vaccines Sales by Country (2016-2021) & (M Doses)
Table 55. North America Avian Influenza Vaccines Sales by Country (2022-2027) & (M Doses)
Table 56. North America Avian Influenza Vaccines Revenue by Country (2016-2021) & (US$ Million)
Table 57. North America Avian Influenza Vaccines Revenue by Country (2022-2027) & (US$ Million)
Table 58. Europe Avian Influenza Vaccines Sales by Type (2016-2021) & (M Doses)
Table 59. Europe Avian Influenza Vaccines Sales by Type (2022-2027) & (M Doses)
Table 60. Europe Avian Influenza Vaccines Revenue by Type (2016-2021) & (US$ Million)
Table 61. Europe Avian Influenza Vaccines Revenue by Type (2022-2027) & (US$ Million)
Table 62. Europe Avian Influenza Vaccines Sales by Application (2016-2021) & (M Doses)
Table 63. Europe Avian Influenza Vaccines Sales by Application (2022-2027) & (M Doses)
Table 64. Europe Avian Influenza Vaccines Revenue by Application (2016-2021) & (US$ Million)
Table 65. Europe Avian Influenza Vaccines Revenue by Application (2022-2027) & (US$ Million)
Table 66. Europe Avian Influenza Vaccines Sales by Country (2016-2021) & (M Doses)
Table 67. Europe Avian Influenza Vaccines Sales by Country (2022-2027) & (M Doses)
Table 68. Europe Avian Influenza Vaccines Revenue by Country (2016-2021) & (US$ Million)
Table 69. Europe Avian Influenza Vaccines Revenue by Country (2022-2027) & (US$ Million)
Table 70. Asia Pacific Avian Influenza Vaccines Sales by Type (2016-2021) & (M Doses)
Table 71. Asia Pacific Avian Influenza Vaccines Sales by Type (2022-2027) & (M Doses)
Table 72. Asia Pacific Avian Influenza Vaccines Revenue by Type (2016-2021) & (US$ Million)
Table 73. Asia Pacific Avian Influenza Vaccines Revenue by Type (2022-2027) & (US$ Million)
Table 74. Asia Pacific Avian Influenza Vaccines Sales by Application (2016-2021) & (M Doses)
Table 75. Asia Pacific Avian Influenza Vaccines Sales by Application (2022-2027) & (M Doses)
Table 76. Asia Pacific Avian Influenza Vaccines Revenue by Application (2016-2021) & (US$ Million)
Table 77. Asia Pacific Avian Influenza Vaccines Revenue by Application (2022-2027) & (US$ Million)
Table 78. Asia Pacific Avian Influenza Vaccines Sales by Region (2016-2021) & (M Doses)
Table 79. Asia Pacific Avian Influenza Vaccines Sales by Region (2022-2027) & (M Doses)
Table 80. Asia Pacific Avian Influenza Vaccines Revenue by Region (2016-2021) & (US$ Million)
Table 81. Asia Pacific Avian Influenza Vaccines Revenue by Region (2022-2027) & (US$ Million)
Table 82. Latin America Avian Influenza Vaccines Sales by Type (2016-2021) & (M Doses)
Table 83. Latin America Avian Influenza Vaccines Sales by Type (2022-2027) & (M Doses)
Table 84. Latin America Avian Influenza Vaccines Revenue by Type (2016-2021) & (US$ Million)
Table 85. Latin America Avian Influenza Vaccines Revenue by Type (2022-2027) & (US$ Million)
Table 86. Latin America Avian Influenza Vaccines Sales by Application (2016-2021) & (M Doses)
Table 87. Latin America Avian Influenza Vaccines Sales by Application (2022-2027) & (M Doses)
Table 88. Latin America Avian Influenza Vaccines Revenue by Application (2016-2021) & (US$ Million)
Table 89. Latin America Avian Influenza Vaccines Revenue by Application (2022-2027) & (US$ Million)
Table 90. Latin America Avian Influenza Vaccines Sales by Country (2016-2021) & (M Doses)
Table 91. Latin America Avian Influenza Vaccines Sales by Country (2022-2027) & (M Doses)
Table 92. Latin America Avian Influenza Vaccines Revenue by Country (2016-2021) & (US$ Million)
Table 93. Latin America Avian Influenza Vaccines Revenue by Country (2022-2027) & (US$ Million)
Table 94. Middle East and Africa Avian Influenza Vaccines Sales by Type (2016-2021) & (M Doses)
Table 95. Middle East and Africa Avian Influenza Vaccines Sales by Type (2022-2027) & (M Doses)
Table 96. Middle East and Africa Avian Influenza Vaccines Revenue by Type (2016-2021) & (US$ Million)
Table 97. Middle East and Africa Avian Influenza Vaccines Revenue by Type (2022-2027) & (US$ Million)
Table 98. Middle East and Africa Avian Influenza Vaccines Sales by Application (2016-2021) & (M Doses)
Table 99. Middle East and Africa Avian Influenza Vaccines Sales by Application (2022-2027) & (M Doses)
Table 100. Middle East and Africa Avian Influenza Vaccines Revenue by Application (2016-2021) & (US$ Million)
Table 101. Middle East and Africa Avian Influenza Vaccines Revenue by Application (2022-2027) & (US$ Million)
Table 102. Middle East and Africa Avian Influenza Vaccines Sales by Country (2016-2021) & (M Doses)
Table 103. Middle East and Africa Avian Influenza Vaccines Sales by Country (2022-2027) & (M Doses)
Table 104. Middle East and Africa Avian Influenza Vaccines Revenue by Country (2016-2021) & (US$ Million)
Table 105. Middle East and Africa Avian Influenza Vaccines Revenue by Country (2022-2027) & (US$ Million)
Table 106. Merial Corporation Information
Table 107. Merial Description and Major Businesses
Table 108. Merial Avian Influenza Vaccines Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses) and Gross Margin (2016-2021)
Table 109. Merial Avian Influenza Vaccines Product
Table 110. Merial Recent Developments
Table 111. CEVA Corporation Information
Table 112. CEVA Description and Major Businesses
Table 113. CEVA Avian Influenza Vaccines Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses) and Gross Margin (2016-2021)
Table 114. CEVA Avian Influenza Vaccines Product
Table 115. CEVA Recent Developments
Table 116. Zoetis Corporation Information
Table 117. Zoetis Description and Major Businesses
Table 118. Zoetis Avian Influenza Vaccines Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses) and Gross Margin (2016-2021)
Table 119. Zoetis Avian Influenza Vaccines Product
Table 120. Zoetis Recent Developments
Table 121. Elanco (Lohmann ) Corporation Information
Table 122. Elanco (Lohmann ) Description and Major Businesses
Table 123. Elanco (Lohmann ) Avian Influenza Vaccines Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses) and Gross Margin (2016-2021)
Table 124. Elanco (Lohmann ) Avian Influenza Vaccines Product
Table 125. Elanco (Lohmann ) Recent Developments
Table 126. Merck Animal Health Corporation Information
Table 127. Merck Animal Health Description and Major Businesses
Table 128. Merck Animal Health Avian Influenza Vaccines Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses) and Gross Margin (2016-2021)
Table 129. Merck Animal Health Avian Influenza Vaccines Product
Table 130. Merck Animal Health Recent Developments
Table 131. Avimex Animal Health Corporation Information
Table 132. Avimex Animal Health Description and Major Businesses
Table 133. Avimex Animal Health Avian Influenza Vaccines Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses) and Gross Margin (2016-2021)
Table 134. Avimex Animal Health Avian Influenza Vaccines Product
Table 135. Avimex Animal Health Recent Developments
Table 136. Key Raw Materials Lists
Table 137. Raw Materials Key Suppliers Lists
Table 138. Avian Influenza Vaccines Distributors List
Table 139. Avian Influenza Vaccines Customers List
Table 140. Avian Influenza Vaccines Market Trends
Table 141. Avian Influenza Vaccines Market Drivers
Table 142. Avian Influenza Vaccines Market Challenges
Table 143. Avian Influenza Vaccines Market Restraints
Table 144. Research Programs/Design for This Report
Table 145. Key Data Information from Secondary Sources
Table 146. Key Data Information from Primary Sources
List of Figures
Figure 1. Avian Influenza Vaccines Product Picture
Figure 2. Global Avian Influenza Vaccines Market Share by Type in 2020 & 2027
Figure 3. Type H5 Product Picture
Figure 4. Type H9 Product Picture
Figure 5. Other Product Picture
Figure 6. Global Avian Influenza Vaccines Sales Market Share by Application in 2020 & 2027
Figure 7. Chicken
Figure 8. Duck & Goose
Figure 9. Other
Figure 10. Avian Influenza Vaccines Report Years Considered
Figure 11. Global Avian Influenza Vaccines Sales 2016-2027 (M Doses)
Figure 12. Global Avian Influenza Vaccines Revenue, (US$ Million), 2016 VS 2021 VS 2027
Figure 13. Global Avian Influenza Vaccines Revenue 2016-2027 (US$ Million)
Figure 14. Global Avian Influenza Vaccines Revenue Market Share by Region in Percentage: 2020 Versus 2027
Figure 15. Global Avian Influenza Vaccines Sales Market Share by Region (2016-2021)
Figure 16. Global Avian Influenza Vaccines Sales Market Share by Region (2022-2027)
Figure 17. North America Avian Influenza Vaccines Sales YoY (2016-2027) & (M Doses)
Figure 18. North America Avian Influenza Vaccines Revenue YoY (2016-2027) & (US$ Million)
Figure 19. Europe Avian Influenza Vaccines Sales YoY (2016-2027) & (M Doses)
Figure 20. Europe Avian Influenza Vaccines Revenue YoY (2016-2027) & (US$ Million)
Figure 21. Asia-Pacific Avian Influenza Vaccines Sales YoY (2016-2027) & (M Doses)
Figure 22. Asia-Pacific Avian Influenza Vaccines Revenue YoY (2016-2027) & (US$ Million)
Figure 23. Latin America Avian Influenza Vaccines Sales YoY (2016-2027) & (M Doses)
Figure 24. Latin America Avian Influenza Vaccines Revenue YoY (2016-2027) & (US$ Million)
Figure 25. Middle East & Africa Avian Influenza Vaccines Sales YoY (2016-2027) & (M Doses)
Figure 26. Middle East & Africa Avian Influenza Vaccines Revenue YoY (2016-2027) & (US$ Million)
Figure 27. The Top 10 and Top 5 Players Market Share by Avian Influenza Vaccines Sales in 2020
Figure 28. The Top 10 and Top 5 Players Market Share by Avian Influenza Vaccines Revenue in 2020
Figure 29. Avian Influenza Vaccines Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2016 VS 2020
Figure 30. Global Avian Influenza Vaccines Sales Market Share by Type (2016-2027)
Figure 31. Global Avian Influenza Vaccines Revenue Market Share by Type (2016-2027)
Figure 32. Global Avian Influenza Vaccines Sales Market Share by Application (2016-2027)
Figure 33. Global Avian Influenza Vaccines Revenue Market Share by Application (2016-2027)
Figure 34. North America Avian Influenza Vaccines Sales Market Share by Type (2016-2027)
Figure 35. North America Avian Influenza Vaccines Revenue Market Share by Type (2016-2027)
Figure 36. North America Avian Influenza Vaccines Sales Market Share by Application (2016-2027)
Figure 37. North America Avian Influenza Vaccines Revenue Market Share by Application (2016-2027)
Figure 38. North America Avian Influenza Vaccines Sales Share by Country (2016-2027)
Figure 39. North America Avian Influenza Vaccines Revenue Share by Country (2016-2027)
Figure 40. U.S. Avian Influenza Vaccines Revenue (2016-2027) & (US$ Million)
Figure 41. Canada Avian Influenza Vaccines Revenue (2016-2027) & (US$ Million)
Figure 42. Europe Avian Influenza Vaccines Sales Market Share by Type (2016-2027)
Figure 43. Europe Avian Influenza Vaccines Revenue Market Share by Type (2016-2027)
Figure 44. Europe Avian Influenza Vaccines Sales Market Share by Application (2016-2027)
Figure 45. Europe Avian Influenza Vaccines Revenue Market Share by Application (2016-2027)
Figure 46. Europe Avian Influenza Vaccines Sales Share by Country (2016-2027)
Figure 47. Europe Avian Influenza Vaccines Revenue Share by Country (2016-2027)
Figure 48. Germany Avian Influenza Vaccines Revenue (2016-2027) & (US$ Million)
Figure 49. France Avian Influenza Vaccines Revenue (2016-2027) & (US$ Million)
Figure 50. U.K. Avian Influenza Vaccines Revenue (2016-2027) & (US$ Million)
Figure 51. Italy Avian Influenza Vaccines Revenue (2016-2027) & (US$ Million)
Figure 52. Russia Avian Influenza Vaccines Revenue (2016-2027) & (US$ Million)
Figure 53. Asia Pacific Avian Influenza Vaccines Sales Market Share by Type (2016-2027)
Figure 54. Asia Pacific Avian Influenza Vaccines Revenue Market Share by Type (2016-2027)
Figure 55. Asia Pacific Avian Influenza Vaccines Sales Market Share by Application (2016-2027)
Figure 56. Asia Pacific Avian Influenza Vaccines Revenue Market Share by Application (2016-2027)
Figure 57. Asia Pacific Avian Influenza Vaccines Sales Share by Region (2016-2027)
Figure 58. Asia Pacific Avian Influenza Vaccines Revenue Share by Region (2016-2027)
Figure 59. China Avian Influenza Vaccines Revenue (2016-2027) & (US$ Million)
Figure 60. Japan Avian Influenza Vaccines Revenue (2016-2027) & (US$ Million)
Figure 61. South Korea Avian Influenza Vaccines Revenue (2016-2027) & (US$ Million)
Figure 62. India Avian Influenza Vaccines Revenue (2016-2027) & (US$ Million)
Figure 63. Australia Avian Influenza Vaccines Revenue (2016-2027) & (US$ Million)
Figure 64. Taiwan Avian Influenza Vaccines Revenue (2016-2027) & (US$ Million)
Figure 65. Indonesia Avian Influenza Vaccines Revenue (2016-2027) & (US$ Million)
Figure 66. Thailand Avian Influenza Vaccines Revenue (2016-2027) & (US$ Million)
Figure 67. Malaysia Avian Influenza Vaccines Revenue (2016-2027) & (US$ Million)
Figure 68. Philippines Avian Influenza Vaccines Revenue (2016-2027) & (US$ Million)
Figure 69. Latin America Avian Influenza Vaccines Sales Market Share by Type (2016-2027)
Figure 70. Latin America Avian Influenza Vaccines Revenue Market Share by Type (2016-2027)
Figure 71. Latin America Avian Influenza Vaccines Sales Market Share by Application (2016-2027)
Figure 72. Latin America Avian Influenza Vaccines Revenue Market Share by Application (2016-2027)
Figure 73. Latin America Avian Influenza Vaccines Sales Share by Country (2016-2027)
Figure 74. Latin America Avian Influenza Vaccines Revenue Share by Country (2016-2027)
Figure 75. Mexico Avian Influenza Vaccines Revenue (2016-2027) & (US$ Million)
Figure 76. Brazil Avian Influenza Vaccines Revenue (2016-2027) & (US$ Million)
Figure 77. Argentina Avian Influenza Vaccines Revenue (2016-2027) & (US$ Million)
Figure 78. Middle East and Africa Avian Influenza Vaccines Sales Market Share by Type (2016-2027)
Figure 79. Middle East and Africa Avian Influenza Vaccines Revenue Market Share by Type (2016-2027)
Figure 80. Middle East and Africa Avian Influenza Vaccines Sales Market Share by Application (2016-2027)
Figure 81. Middle East and Africa Avian Influenza Vaccines Revenue Market Share by Application (2016-2027)
Figure 82. Middle East and Africa Avian Influenza Vaccines Sales Share by Country (2016-2027)
Figure 83. Middle East and Africa Avian Influenza Vaccines Revenue Share by Country (2016-2027)
Figure 84. Turkey Avian Influenza Vaccines Revenue (2016-2027) & (US$ Million)
Figure 85. Saudi Arabia Avian Influenza Vaccines Revenue (2016-2027) & (US$ Million)
Figure 86. U.A.E Avian Influenza Vaccines Revenue (2016-2027) & (US$ Million)
Figure 87. Avian Influenza Vaccines Value Chain
Figure 88. Avian Influenza Vaccines Production Process
Figure 89. Channels of Distribution
Figure 90. Distributors Profiles
Figure 91. Bottom-up and Top-down Approaches for This Report
Figure 92. Data Triangulation
Figure 93. Key Executives Interviewed
  • Global Influenza Vaccine Market 2021 by Manufacturers, Regions, Type and Application, Forecast to 2026
    Published: 19-Oct-2021        Price: US 3480 Onwards        Pages: 94
    The Influenza Vaccine market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations. According to our latest resea......
  • Global Avian Influenza Vaccines Market 2021 by Manufacturers, Regions, Type and Application, Forecast to 2026
    Published: 11-Oct-2021        Price: US 3480 Onwards        Pages: 119
    The Avian Influenza Vaccines market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations. According to our lates......
  • Global Encephalitis Vaccination Market 2021 by Manufacturers, Regions, Type and Application, Forecast to 2026
    Published: 07-Oct-2021        Price: US 3480 Onwards        Pages: 87
    The Encephalitis Vaccination market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations. According to our lates......
  • Global 23-Valent Pneumococcal Polysaccharide Vaccine Market 2021 by Manufacturers, Regions, Type and Application, Forecast to 2026
    Published: 07-Oct-2021        Price: US 3480 Onwards        Pages: 84
    The 23-Valent Pneumococcal Polysaccharide Vaccine market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations. A......
  • Global and United States Meningococcal Conjugate Market Size, Status and Forecast 2021-2027
    Published: 06-Oct-2021        Price: US 3900 Onwards        Pages: 106
    Global Meningococcal Conjugate Scope and Market Size Meningococcal Conjugate market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Meningococcal Conjugate market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027. Segment......
  • Global and China H1N1 Vaccines Market Insights, Forecast to 2027
    Published: 05-Oct-2021        Price: US 3900 Onwards        Pages: 142
    H1N1 Vaccines market is segmented by region (country), players, by Type, and by Application. Players, stakeholders, and other participants in the global H1N1 Vaccines market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by region (country), by Type and by Application in terms of revenue and forecast for the period 2016-2027. For China market, this report focuses on the H1N1 Vaccines market size by ......
  • Global and China Encephalitis Vaccine Market Insights, Forecast to 2027
    Published: 21-Sep-2021        Price: US 3900 Onwards        Pages: 142
    Encephalitis Vaccine market is segmented by region (country), players, by Type, and by Application. Players, stakeholders, and other participants in the global Encephalitis Vaccine market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by region (country), by Type and by Application in terms of revenue and forecast for the period 2016-2027. For China market, this report focuses on the Encephalitis Va......
  • United States Influenza Vaccine Market Report & Forecast 2021-2027
    Published: 17-Sep-2021        Price: US 3400 Onwards        Pages: 92
    United States Influenza Vaccine Market, By Type, 2016-2021, 2022-2027 ($ Millions) & (M Doses) United States Influenza Vaccine Market Segment Percentages, By Type, 2020 (%) - Trivalent Influenza Vaccine - Quadrivalent Influenza Vaccine United States Influenza Vaccine Market, By Application, 2016-2021, 2022-2027 ($ Millions) & (M Doses) United States Influenza Vaccine Market Segment Percentages, By Application, 2020 (%) - For Children (6 months to......
  • 2021-2027 Global and Regional 23-Valent Pneumococcal Polysaccharide Vaccine Industry Status and Prospects Professional Market Research Report Standard Version
    Published: 13-Sep-2021        Price: US 3500 Onwards        Pages: 140
    The global 23-Valent Pneumococcal Polysaccharide Vaccine market was valued at 1986.07 Million USD in 2020 and will grow with a CAGR of 14.57% from 2020 to 2027, based on HNY Research newly published report. The prime objective of this report is to provide the insights on the post COVID-19 impact which will help market players in this field evaluate their business approaches. Also, this report covers market segmentation by major market verdors, types, applications/end users and geography(N......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs